Current issues in the identification and treatment of metabolically healthy but obese individuals

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 24, Issue 5, 2014, Pages 455-459

  Plourde, G ^a,b   Karelis, A D ^c  

^a HEALTH CANADA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

Clinical practice; Metabolically healthy obese; Metabolically unhealthy obese; Treatment

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; ECHOGRAPHY; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; KNEE OSTEOARTHRITIS; LIFESTYLE MODIFICATION; METABOLIC SYNDROME X; METABOLICALLY HEALTHY OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY; SLEEP DISORDERED BREATHING; SMOKING; WAIST CIRCUMFERENCE; WEIGHT GAIN; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; DIABETES MELLITUS, TYPE 2; METABOLISM; MORTALITY;

BLOOD GLUCOSE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; HUMANS; METABOLIC SYNDROME X; OBESITY; PREVALENCE; RISK FACTORS; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84899082178     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2013.12.002     Document Type: Short Survey

References (34)

1. Karelis A.D. Metabolically healthy but obese individuals. Lancet 2008, 372:1281-1283.
2. Tremblay A., Doucet E., Imbeault P., Mauriège P., Després J.P., Richard D. Metabolic fitness in active reduced-obese individuals. Obes Res 1999, 7:556-563.
3. Manu P., Ionescu-Tirgoviste C., Tsang J., Napolitano B.A., Lesser M.L., Correll C.U. Dysmetabolic signals in "Metabolically Healthy"" obesity. Obes Res Clin Pract 2012, 6:e9-e20.
4. Primeau V., Coderre L., Karelis A.D., Brochu M., Lavoie M.E., Messier V., et al. Characterizing the profile of obese patients who are metabolically healthy. Int J Obes (Lond) 2011, 35:971-981.
5. Alberti K.G., Zimmet P., Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006, 23:469-480.
6. Huang Y., Wang S., Cai X., Mai W., Hu Y., Tang H., et al. Prehypertension and incidence of cardiovascular disease: a meta-analysis. BMC Med 2013, 11:177.
7. Velho S., Paccaud F., Waeber G., Vollenweider P., Marques-Vidal P. Metabolically healthy obesity: different prevalences using different criteria. Eur J Clin Nutr 2010, 64:1043-1051.
8. Wildman R.P., Muntner P., Reynolds K., et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008, 168:1617-1624.
9. Hamer M., Stamatakis E. Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab 2012, 97:2482-2488.
10. Calori G., Lattuada G., Piemonti L., Garancini M.P., Ragogna F., Villa M., et al. Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 2011, 34:210-215.
11. Meigs J.B., Wilson P.W., Fox C.S., et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006, 91:2906-2912.
12. Kuk J.L., Ardern C.I. Are metabolically normal but obese individuals at lower risk for all-cause mortality?. Diabetes Care 2009, 32:2297-2299.
13. Arnlov J., Ingelsson E., Sundstrom J., Lind L. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 2010, 121:230-236.
14. Chang Y., Ryu S., Suh B.S., Yun K.E., Kim C.W., Cho S.I. Impact of BMI on the incidence of metabolic abnormalities in metabolically healthy men. Int J Obes (Lond) 2012, 36:1187-1194.
15. Park J., Kim S.H., Cho G.Y., Baik I., Kim N.H., Lim H.E., et al. Obesity phenotype and cardiovascular changes. J Hypertens 2011, 29:1765-1772.
16. Hinnouho G.M., Czernichow S., Dugravot A., Batty G.D., Kivimaki M., Singh-Manoux A. Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter?. Diabetes Care 2013, 36:2294-2300.
17. Kramer C.K., Zinman B., Retnakaran R. Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis. Ann Intern Med 2013, 159:758-769.
18. Appleton S.L., Seaborn C.J., Visvanathan R., Hill C.L., Gill T.K., Taylor A.W., et al. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study. Diabetes Care 2013, 36:2388-2394.
19. Karelis A.D., Faraj M., Bastard J.P., St-Pierre D.H., Brochu M., Prud'homme D., et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 2005, 90:4145-4150.
20. Hankinson A.L., Daviglus M.L., Van Horn L., Chan Q., Brown I., Holmes E., et al. Diet composition and activity level of at risk and metabolically healthy obese American adults. Obesity (Silver Spring) 2013, 21:637-643.
21. Phillips C.M., Dillon C., Harrington J.M., McCarthy V.J., Kearney P.M., Fitzgerald A.P. Defining metabolically healthy obesity: role of dietary and lifestyle factors. PLoS One 2013, 8:e76188.
22. Berrahmoune H., Herbeth B., Samara A., Marteau J.B., Siest G., Visvikis-Siest S. Five-year alterations in BMI are associated with clustering of changes in cardiovascular risk factors in a gender-dependant way: the Stanislas study. Int J Obes (Lond) 2008, 32:1279-1288.
23. Lau D.C., Douketis J.D., Morrison K.M., Hramiak I.M., Sharma A.M., Ur E., et al. 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. CMAJ: Can Med Assoc 2007, 176:S1-13.
24. Kantartzis K., Machann J., Schick F., Rittig K., Machicao F., Fritsche A., et al. Effects of a lifestyle intervention in metabolically benign and malign obesity. Diabetologia 2011, 54:864-868.
25. Karelis A.D., Messier V., Brochu M., Rabasa-Lhoret R. Metabolically healthy but obese women: effect of an energy-restricted diet. Diabetologia 2008, 51:1752-1754.
26. Shin M.J., Hyun Y.J., Kim O.Y., Kim J.Y., Jang Y., Lee J.H. Weight loss effect on inflammation and LDL oxidation in metabolically healthy but obese (MHO) individuals: low inflammation and LDL oxidation in MHO women. Int J Obes (Lond) 2006, 30:1529-1534.
27. Janiszewski P.M., Ross R. Effects of weight loss among metabolically healthy obese men and women. Diabetes Care 2010, 33:1957-1959.
28. Gilardini L., Vallone L., Cottafava R., Redaelli G., Croci M., Conti A., et al. Insulin sensitivity deteriorates after short-term lifestyle intervention in the insulin sensitive phenotype of obesity. Obesity facts 2012, 5:68-76.
29. Evangelou P., Tzotzas T., Christou G., Elisaf M.S., Kiortsis D.N. Does the presence of metabolic syndrome influence weight loss in obese and overweight women?. Metab Syndrome Relat Disorder 2010, 8:173-178.
30. Sesti G., Folli F., Perego L., Hribal M.L., Pontiroli A.E. Effects of weight loss in metabolically healthy obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet. PloS One 2011, 6:e17737.
31. Bouchard C., Blair S.N., Church T.S., Earnest C.P., Hagberg J.M., Häkkinen K., et al. Adverse metabolic response to regular exercise: is it a rare or common occurrence?. PLoS One 2012, 7:e37887.
32. Kodama S., Saito K., Tanaka S., Maki M., Yachi Y., Asumi M., et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA 2009, 301:2024-2035.
33. Ortega F.B., Lee D.C., Katzmarzyk P.T., Ruiz J.R., Sui X., Church T.S., et al. The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Eur Heart J 2013, 34:389-397.
34. Plourde G., Prud'homme D. Mangaing obesity in adults in primary care. CMAJ 2012, 184:1039-1044.